ProPac Ion Exchange Columns for Protein Analysis

Importance of the topic

Ion exchange chromatography of proteins enables separation of closely related variants by charge differences and is critical in biopharmaceutical characterization and quality control

Objectives and overview

This study evaluates a series of ProPac ion exchange columns designed for high resolution and reproducible separation of protein charge variants across sequence truncation phosphorylation sialylation and deamidation modifications

Methodology and instrumentation

The approach relies on rigid nonporous pellicular resins with grafted ion exchange polymers and a hydrophilic boundary film to minimize secondary interactions Gradient elutions with phosphate acetate or Tris buffers and NaCl are applied to separate variants on weak or strong cation and anion exchange phases

Used Instrumentation

• ProPac WCX-10 SCX-10 SAX-10 WAX-10 columns in analytical semipreparative and guard formats
• Column dimensions 2 4 9 and 22 mm id by 250 mm length
• Buffers phosphate acetate Tris HCl with linear or step gradients
• Flow rates typically 1 mL per minute and injection volumes 10 to 50 μL
• Detection at 214 220 or 280 nm

Main results and discussion

• Sequence variants Hemoglobin F S and C resolved by ProPac SCX-10 with baseline separation of clinical variants
• Truncation variants Humanized IgG1 monoclonal antibody C-terminal lysine variants separated by ProPac WCX-10 before and after carboxypeptidase B treatment
• Phosphorylation variants Ovalbumin isoforms separated by ProPac SAX-10 gradient elution with eight resolved peaks collapsing on dephosphorylation
• Sialylation variants Transferrin sialylation forms show distinct elution profiles that converge after neuraminidase digestion
• Deamidation variants Ribonuclease A and its two deamidation products resolved by ProPac WCX-10 enabling time-course quantification

Benefits and practical applications

ProPac columns deliver high resolving power rapid mass transfer and reproducible performance eliminating lot variability This supports biopharmaceutical method development quality control clinical assays and biomarker analysis

Future trends and possibilities

Integration with mass spectrometry advanced polymer chemistries novel mixed mode and multimodal resins miniaturized formats and automated high throughput workflows are anticipated to expand capabilities in proteoform analysis and biopharmaceutical characterization

Conclusion

The ProPac line offers robust ion exchange solutions for separating complex protein charge variants achieving baseline resolution across multiple modification types and ensuring consistent results for research development and regulatory environments

Reference

1. Basset P Braconnier F Rosa J J Chromatogr 1982 227 267 304
2. Weitzhandler M Farnan D Horvath J Rohrer J Slingsby R Avdalovic N Pohl C J Chromatogr A 1998 828 365 372
3. Frenz J Quan C Cacia J Democko C Bridenbaugh R McNerney T Anal Chem 1994 66 335 340
4. Stibler H Clin Chem 1991 37 2029 2039
5. Rohrer J S Avdalovic N Protein Expression and Purification 1994 7 39 44
6. Aswad D W Deamidation and Isoaspartate Formation in Peptides and Proteins CRC Press 1995